NHS To Offer Variant-Busting Booster Before The Winters
The NHS has now laid out plans for the next stage of the COVID-19 vaccination effort, the biggest and most rapid vaccine drive in...
Evidence Shows Alzheimer Benefits From Genuv Cancer Drug
Mekinist (trametinib), which has been licenced by the FDA for the treatment of melanoma, was shown in a preclinical trial to have a neuroprotective...
Auvelity- A Possible Game Depression Treatment, Says Axsome
It is commonly known that there are insufficient therapy choices for major depressive disorder. Then the pandemic struck, increasing the number of patients with...
Vaccine Cos Brace For Busy Months As Fear Of Influenza Looms
Flu season is just around the horizon as the summer draws to a close and fall looms. Influenza still poses a threat, and leading...
FDA Approves Zynteglo $2.8M Gene Treatment From Bluebird Bio
Gene therapy for blood disorders developed by Bluebird Bio has already left the nest in the US.
Zynteglo, sometimes known as betibeglogene autotemcel (beti-cel), was...
ADCs Developed By Starpharma Will Be Evaluated By Merck
As it works to expand its antibody-drug conjugate (ADC) capabilities, Merck has strengthened its links to Starpharma by signing a second partnership that will...
Bayer Hires Lobbyists After Roe To Push Contraception Access
While a large portion of the biopharma industry prepares for a battle over medication prices, Bayer is getting ready for a different lobbying push...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...